4 References 34. Boss GR, Seegmiller JE. Age-Related Physiological Changes and Their Clinical Significance. The Western Journal of Medicine. 1981; 135: 434– 440 doi: Not available. 35. Dodds CM, Kumar CM, Veering BT. Oxford Textbook of Anaesthesia for the Elderly Patient. Oxford University Press, 2014. doi: Not available. 36. L¨otsch J, Stockmann A, Kobal G, Brune K, Waibel R, Schmidt N, Geisslinger G. Pharmacokinetics of Morphine and Its Glucuronides After Intravenous Infusion of Morphine and Morphine-6-Glucuronide in Healthy Volunteers. Clinical Pharmacology Therapeutics. 1996; 60: 316–325 doi: 10.1016/S0009-9236(96)90058-2. 37. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and Pharmacodynamics of Remifentanil. II. Model Application. Anesthesiology. 1997; 86: 24–33 doi: 10.1097/00000542-199701000-00005. 38. Crugten JT van, Somogyi AA, Nation RL, Reynolds GR. The Effect of Age on the Disposition and Antinociceptive Response of Morphine and Morphine-6-Glucuronide in the Rat. Pain. 1997; 71: 199–205 doi: 10.1016/S0304-3959(97)03363-0. 39. Olofsen E, Dorp E van, Teppma L, Aarts L, Smith T, Dahan A, Sarton E. Naloxone Reversal of Morphine- and Morphine-6-Glucuronide-Induced Respiratory Depression in Humans. Anesthesiology. 2010; 212: 1417–1427 doi: 10.1097/ALN.0b013e3181d5e29d. 40. Vuyk J. Pharmacodynamics in the Elderly. Best Practice Research Clinical Anaesthesiology. 2003; 17: 207–218 doi: 10.1016/S1521-6896(03)00008-9. 41. Bowie MW, Slattum PW. Pharmacodynamics in Older Adults: A Review. The American Journal of Geriatric Pharmacotherapy. 2007; 5: 263–303 doi: 10.1016/j.amjopharm.2007.10.001. 42. Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL. Side Effects of Opioids During Short-Term Administration: Effect of Age, Gender, and Race. Clinical Pharmacology Therapeutics. 2003; 74: 102–112 doi: 10.1016/S0009-9236(03)00152-8. 43. Scott JC, Stanski DR. Decreased Fentanyl and Alfentanil Dose Requirements with Age: A Simultaneous Pharmacokinetic and Pharmacodynamic Evaluation. Journal of Pharmacology and Experimental Therapeutics. 1987; 240: 159–166 doi: PMID 3100765. 97
RkJQdWJsaXNoZXIy MTk4NDMw